Search Results - "WILLENHEIMER, Ronnie"
-
1
Incidence of Cancer and Mortality in Patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Trial
Published in The American journal of cardiology (15-11-2014)“…The Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) clinical trial, including 1,873 patients found an increased risk for cancer with lipid-lowering therapy…”
Get full text
Journal Article -
2
Design and Baseline Characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study
Published in The American journal of cardiology (01-04-2007)“…Aortic valve stenosis and atherosclerotic disease have several risk factors in common, in particular, hypercholesterolemia. Histologically, the diseased valves…”
Get full text
Journal Article -
3
Observed and Predicted Reduction of Ischemic Cardiovascular Events in the Simvastatin and Ezetimibe in Aortic Stenosis Trial
Published in The American journal of cardiology (15-06-2010)“…In the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial, combined ezetimibe (10 mg) and simvastatin (40 mg) decreased low-density lipoprotein…”
Get full text
Journal Article -
4
Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis
Published in Heart (British Cardiac Society) (01-01-2014)“…To account for differences in body size in patients with aortic stenosis, aortic valve area (AVA) is divided by body surface area (BSA) to calculate indexed…”
Get more information
Journal Article -
5
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study
Published in International journal of cardiology (05-06-2013)“…Abstract Background The frequency and prognostic importance of atrial fibrillation (AF) in asymptomatic mild-to-moderate aortic stenosis (AS) has not been well…”
Get full text
Journal Article -
6
Extracellular matrix biomarker, fibulin-1, is closely related to NT-proBNP and soluble urokinase plasminogen activator receptor in patients with aortic valve stenosis (the SEAS study)
Published in PloS one (11-07-2014)“…Fibulin-1, a circulating extracellular matrix glycoprotein, has been associated with arterial disease and elevated N-terminal prohormone B-type natriuretic…”
Get full text
Journal Article -
7
Impact of Baseline Severity of Aortic Valve Stenosis on Effect of Intensive Lipid Lowering Therapy (from the SEAS Study)
Published in The American journal of cardiology (01-12-2010)“…Retrospective studies have suggested a beneficial effect of lipid-lowering treatment on the progression of aortic stenosis (AS) in milder stages of the…”
Get full text
Journal Article -
8
Aortic stenosis and mitral regurgitation as predictors of atrial fibrillation during 11 years of follow-up
Published in BMC cardiovascular disorders (18-10-2012)“…There is limited information about any association between the onset of atrial fibrillation (AF) and the presence of valvular disease. We retrospectively…”
Get full text
Journal Article -
9
The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: a cross-sectional analysis within the Malmö Preventive Project
Published in Cardiovascular diabetology (28-12-2011)“…The increased risk of cardiovascular disease (CVD) in diabetic compared to non-diabetic subjects seems to decrease with age. Whether this age-related reduction…”
Get full text
Journal Article -
10
Differences in Cardiovascular Risk Profile Between Electrocardiographic Hypertrophy Versus Strain in Asymptomatic Patients With Aortic Stenosis (from SEAS Data)
Published in The American journal of cardiology (15-08-2011)“…Electrocardiograms are routinely obtained in clinical follow-up of patients with asymptomatic aortic stenosis (AS). The association with aortic valve, left…”
Get full text
Journal Article -
11
Myocardial structure and function by echocardiography in relation to glucometabolic status in elderly subjects from 2 population-based cohorts: A cross-sectional study
Published in The American heart journal (01-03-2010)“…Background Left ventricular (LV) diastolic dysfunction has been associated with impaired glucometabolic status. However, studies of older subjects are lacking…”
Get full text
Journal Article -
12
High-sensitive cardiac Troponin T is superior to echocardiography in predicting 1-year mortality in patients with SIRS and shock in intensive care
Published in BMC anesthesiology (24-09-2012)“…Left ventricular (LV) dysfunction is well documented in the critically ill. We assessed 1-year mortality in relation to cardiac biomarkers and LV function…”
Get full text
Journal Article -
13
The prognostic importance of body mass index after complicated myocardial infarction
Published in Journal of the American College of Cardiology (04-01-2005)“…Obesity may confer excess risk by producing an inflammatory state, promoting thrombosis and activating the sympathetic nervous system and the renin-angiotensin…”
Get full text
Journal Article -
14
Impact of QRS Duration and Morphology on the Risk of Sudden Cardiac Death in Asymptomatic Patients With Aortic Stenosis
Published in Journal of the American College of Cardiology (27-03-2012)“…Objectives The aim of the study was to examine the predictive value of QRS duration and morphology during watchful waiting in asymptomatic patients with aortic…”
Get full text
Journal Article -
15
Quantitative detection of myocardial ischaemia by stress echocardiography; a comparison with SPECT
Published in Cardiovascular ultrasound (18-06-2009)“…Real-time perfusion (RTP) adenosine stress echocardiography (ASE) can be used to visually evaluate myocardial ischaemia. The RTP power modulation technique…”
Get full text
Journal Article -
16
Head to head comparisons of two modalities of perfusion adenosine stress echocardiography with simultaneous SPECT
Published in Cardiovascular ultrasound (20-04-2009)“…Real-time perfusion (RTP) contrast echocardiography can be used during adenosine stress echocardiography (ASE) to evaluate myocardial ischemia. We compared two…”
Get full text
Journal Article -
17
Angiotensin receptor blockers in heart failure after the ELITE II trial
Published in Current controlled trials in cardiovascular medicine (12-09-2000)“…Specific blockers of the angiotensin type1 receptor, angiotensin receptor blockers (ARBs), have been introduced as an alternative to angiotensin-converting…”
Get full text
Journal Article -
18
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
Published in The New England journal of medicine (17-12-2009)“…In patients with heart failure and iron deficiency, intravenous iron therapy improved functional capacity and the quality of life. The benefit was similar in…”
Get full text
Journal Article -
19
Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
Published in The New England journal of medicine (25-09-2008)“…In this randomized, placebo-controlled trial, the combination of simvastatin and ezetimibe had no effect on the progression of aortic stenosis, despite…”
Get full text
Journal Article -
20
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study
Published in European heart journal (01-01-2013)“…Patients with chronic heart failure (CHF) show impaired health-related quality of life (HRQoL), an important target for therapeutic intervention. Impaired iron…”
Get full text
Journal Article